Cross-referencing clinical data
A pairing appears on this page only when a trial gave both ingredients together and measured the result. Chymopapain has none that clears that bar.
Stitching two separate single-ingredient studies into a pairing is the one thing this engine will not do. When a study of the combination itself holds up at source, it lands here with its citation.
No invented synergy. Where actives were studied on their own rather than together, the record shows each on its own evidence, never a combined effect no trial measured.
Research strength. Research strength says how much work stands behind the combination. It is never a product score.
Independent record. Every finding is cited to a named trial, dated, and never written by the brand.
20 pairings are live across the library today. Checked 20 July 2026.
No study gave these as a pair, so they are not in the card above. But the reason they belong together is settled biochemistry, not a guess, so it is worth knowing.
Chymopapain's active site depends on a cysteine thiol that oxidises readily to an inactive disulfide on exposure to air. A reducing thiol such as L-cysteine regenerates the active form, which is why cysteine or a comparable reductant appears in nearly every chymopapain assay buffer. Without it the enzyme measures as inactive even when the protein is intact.
N-acetylcysteine performs the same job as free cysteine in keeping the catalytic thiol reduced, with better stability in a dry blend. This is formulation chemistry rather than a physiological pairing. It affects whether the enzyme is active in the bottle, not what happens in a person.
Papain and chymopapain are co-secreted in papaya latex and share the papain-family fold and catalytic mechanism, though chymopapain is the more abundant of the two in crude latex and differs in substrate preference and isoelectric point. Crude papain preparations therefore usually carry chymopapain whether or not the label says so. Anyone with a papaya latex sensitivity should count them as one exposure.
Bromelain is a cysteine protease from pineapple with a different cleavage preference, so blends cover a wider range of peptide bonds than either alone. The practice is standard in proteolytic enzyme formulas. Broader cleavage coverage is a chemistry statement, not a demonstrated clinical advantage.
Protein, starch and fat need different enzymes, so a protease is combined with amylase and lipase to cover a mixed meal. Chymopapain contributes the protease side. The pairing is formulation convention.
Ascorbate helps hold the surrounding redox environment in a reduced state, which indirectly protects a catalytic thiol from oxidation. It is a weaker and less direct protectant than a dedicated thiol reductant. Useful as a secondary stabiliser in a blend rather than as the primary one.
Nothing specific on file for Chymopapain. Match the label to the daily amount above, and tell your doctor what you take.
Not medical advice. Show the label to your pharmacist.These are the studies our verdict leans on, chosen from the 1 we read for Chymopapain. The full linked list is below.
Read this carefully. These are 26 voluntary, unverified reactions reported to the FDA (openFDA). The number mostly reflects how popular Chymopapain is, not how risky it is. A report is not proof Chymopapain caused anything. It is a signal of what to watch for, nothing more.
Source: openFDA adverse-event reports. Voluntary reporting, not an incidence rate.
FDA Disclaimer: These statements have not been evaluated by the Food and Drug Administration. This information is for educational purposes only and is not intended to diagnose, treat, cure, or prevent any disease. Consult your healthcare provider before starting any supplement regimen.